Berlin: A team of researchers at Goethe University and the Frankfurt University Hospital in Germany have reportedly discovered a series of compounds that resulted in restricting SARS-CoV-2, the virus that causes COVID disease from reproducing.
While the present conclusions are based on a cell structure system, it requires further testing.
Since the virus develops on protein synthesis in the human body, the researchers used translation inhibitors which stopped protein production, resulting in controlling the deadly virus to grow further, the study said.
“Thanks to the mePROD-technology we developed, we were for the first time able to trace the cellular changes upon infection over time and with high detail in our laboratory. We were obviously aware of the potential scope of our findings,” researcher, Christian Munch from Goethe University told media.
The researchers developed 2-Deoxy-D-Glucose (2-DG), among other substances to interfere directly with the carbohydrate metabolism and stop the viral reproduction, the study suggested.
Notably, the substances used are components of already approved medication for treating coronavirus, a researcher added.
Meanwhile, companies in the US and Canada are reportedly preparing for clinical trials based on the current findings with a different substance.
Also Read: COVID-19 Vaccine Needs Animal Trial Before Human Application: ILS Director
Comments are closed.